Sign In
Buy SOPH
$5.67
-0.0900 (-1.56%)
At Close: Jul 31, 2026
Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026
08:00am, Thursday, 16'th Apr 2026
SAN DIEGO and NEW YORK, April 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, today announced that the Mount Sinai Health System, one of the
SOPHiA GENETICS (NASDAQ:SOPH) & Hims & Hers Health (NYSE:HIMS) Financial Comparison
01:58am, Sunday, 15'th Mar 2026
Hims and Hers Health (NYSE: HIMS - Get Free Report) and SOPHiA GENETICS (NASDAQ: SOPH - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies ba
SOPHiA GENETICS Q4 Earnings Call Highlights
02:34am, Thursday, 05'th Mar 2026
SOPHiA GENETICS (NASDAQ: SOPH) executives highlighted accelerating commercial momentum, expanding platform capabilities, and improved profitability outlook during the company's fourth-quarter and full
SOPHiA GENETICS SA (SOPH) Q4 2025 Earnings Call Transcript
12:32pm, Tuesday, 03'rd Mar 2026
SOPHiA GENETICS SA (SOPH) Q4 2025 Earnings Call Transcript
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results
06:45am, Tuesday, 03'rd Mar 2026
BOSTON and ROLLE, Switzerland, March 3, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the fourth quarter a
SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference
08:00am, Wednesday, 25'th Feb 2026
BOSTON and ROLLE, Switzerland, Feb. 25, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced that leadership will present at TD Cowen'
SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026
08:00am, Tuesday, 17'th Feb 2026
BOSTON and ROLLE, Switzerland, Feb. 17, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for
SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems
09:22am, Tuesday, 10'th Feb 2026
BOSTON and ROLLE, Switzerland, Feb. 10, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, today announced the addition of two of the largest U.S. h
Comparing SOPHiA GENETICS (NASDAQ:SOPH) & Precipio (NASDAQ:PRPO)
01:43am, Monday, 02'nd Feb 2026
Precipio (NASDAQ: PRPO - Get Free Report) and SOPHiA GENETICS (NASDAQ: SOPH - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses b
SOPHiA GENETICS (NASDAQ:SOPH) versus Pulmonx (NASDAQ:LUNG) Critical Comparison
01:10am, Sunday, 01'st Feb 2026
SOPHiA GENETICS (NASDAQ: SOPH - Get Free Report) and Pulmonx (NASDAQ: LUNG - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two compa
1,409,160 Shares in SOPHiA GENETICS SA $SOPH Bought by Alta Wealth Advisors LLC
03:38am, Tuesday, 27'th Jan 2026
Alta Wealth Advisors LLC purchased a new stake in SOPHiA GENETICS SA (NASDAQ: SOPH) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The
The Company finishes 2025 with strong Q4 performance, expects 20-22% revenue growth in 2026, and promotes Ross Muken to CEO BOSTON and ROLLE, Switzerland, Jan. 12, 2026 /PRNewswire/ -- SOPHiA GENETIC
Analyzing MSP Recovery (NASDAQ:MSPR) & SOPHiA GENETICS (NASDAQ:SOPH)
01:28am, Monday, 12'th Jan 2026
SOPHiA GENETICS (NASDAQ: SOPH - Get Free Report) and MSP Recovery (NASDAQ: MSPR - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two bus
SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology
08:00am, Wednesday, 07'th Jan 2026
BOSTON and HOUSTON, Jan. 7, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and The University of Texas MD Anderson Cancer Center today announced
SOPHiA GENETICS (NASDAQ:SOPH) Trading 2.8% Higher – What’s Next?
02:07am, Saturday, 27'th Dec 2025
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH - Get Free Report) shot up 2.8% during mid-day trading on Friday. The company traded as high as $4.75 and last traded at $4.73. 45,371 shares traded hands du
